Loading...
XSHG
688626
, Last price  
Name

Xiangyu Medical Co Ltd

Chart & performance

D1W1MN
XSHG:688626 chart
P/E
—
P/S
—
EPS
0.49
Vol. 1Y
—
Shs. 5Y
5.22%
Rev. 5Y
9.15%
Div Yld LY
—
Div Yld TTM
—
Revenues
768m
+3.26%
289,135,948358,857,506427,414,970495,513,744523,496,223488,529,430744,810,202743,531,309767,747,400
Net income
78m
-24.08%
64,474,21180,327,300128,976,315196,263,022201,897,378125,470,153227,142,677102,943,56078,156,441
CFO
190m
+6.28%
59,312,94274,199,040155,943,755216,403,459165,880,603186,703,174227,908,629178,594,439189,816,779
Dividend
Jun 17, 20260.18 /sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Xiangyu Medical Co.,Ltd engages in the research and development, manufacture, and marketing of rehabilitation and physiotherapy equipment in China. It provides various therapy such as smart occupational, electro, sport, rehab, cold and heat, gait training device, hydrotherapy, air compression, phototherapy, traction table, magnetic, CPM, occupational, shock wave and ultrasound, massage, treatment table, tilt table, therapy, micro and shock wave therapy. The company was incorporated in 2002 and is based in Anyang, China.
IPO date
Mar 31, 2021
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT